Titre:domain therapeutics - your partner in gpcr drug discovery
La description :domain therapeutics, a strategic partner of pharmaceutical companies, is aimed at discovering new drug candidates targeting g-protein coupled receptors (gpcrs) in all major therapeutic fields....
Classement Alexa Global: # 6,423,117
Server:Apache... X-Powered-By:PHP/5.3.29
L'adresse IP principale: 213.186.33.2,Votre serveur France,Roubaix
ISP:OVH SAS TLD:com Code postal:fr
Ce rapport est mis à jour en 10-Jun-2018
Created Date:
2008-10-25
Changed Date:
2017-01-27
Données techniques du domaintherapeutics.com
Geo IP vous fournit comme la latitude, la longitude et l'ISP (Internet Service Provider) etc. informations.
Notre service GeoIP a trouvé l'hôte domaintherapeutics.com.Actuellement, hébergé dans France et son fournisseur de services est OVH SAS .
Les informations d'en-tête HTTP font partie du protocole HTTP que le navigateur d'un utilisateur envoie à appelé Apache contenant les détails de ce que le navigateur veut et acceptera de nouveau du serveur Web.
MX preference = 1, mail exchanger = domaintherapeutics-com.mail.protection.outlook.com.
HtmlToText
introduction en bourse - cliquez ici -- contact us -- about management board of directors scientific advisory board investors research & technology r & d dtect-all tm biosens-all tm pipeline pipeline partnering product description partnering news press releases greetings art art'vertising contact us we bring you beyond gpcrs about management board of directors scientific advisory board investors research & technology r & d dtect-all tm biosens-all tm pipeline pipeline partnering product description partnering news press releases greetings art art'vertising the company domain therapeutics, a french and canadian privately-held biopharmaceutical company, is using transmembrane and g protein-coupled receptor (gpcr) targeting for the discovery and development of innovative therapeutics for the treatment of central nervous system (cns) diseases and cancer. using its commercially proven candidate discovery engine ( takeda , merck serono and ono pharmaceutical ), domain has created a pipeline of high-value projects and partnerships. validating this approach, two projects discovered by domain therapeutics technologies are planned to enter clinical phase i in early and late 2016. domain therapeutics applies a multi-string corporate strategy to grow its business through: validation of its technologies through collaborative partnerships with pharma/biotechs, generation of an internal pipeline of 1st in class drug candidates for high unmet needs in cns and oncology, valuation of its preclinical assets through spin-out vehicles, financed by leading investment funds or supported by development-only companies. march 20, 2018 domain therapeutics' business model validated : lundbeck acquires prexton therapeutics for $1.1b learn more... february 27, 2018 bms takes license to biosens-all™ technology learn more... september 06, 2017 domain therapeutics and 5 satts announce an innovative commercial and scientific partnership to accelerate drug development in france learn more... august 23, 2017 domain therapeutics will attend the 9th international meeting on metabotropic glutamate receptors, october 1st -6th in taormina, sicily, and co-present with prexton therapeutics a poster about the discovery, characterization and anti-parkinsonian effect of a novel mglur4 pam chemical series that led to foliglurax, the first mglur4 pam compound in clinical trial 9th international meeting on metabotropic glutamate receptors, learn more... × greetings from domain therapeutics
Whois est un protocole qui permet d'accéder aux informations d'enregistrement.Vous pouvez atteindre quand le site Web a été enregistré, quand il va expirer, quelles sont les coordonnées du site avec les informations suivantes. En un mot, il comprend ces informations;
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
REGISTRAR OVH
SERVERS
SERVER com.whois-servers.net
ARGS domain =domaintherapeutics.com
PORT 43
TYPE domain RegrInfo DOMAIN
NAME domaintherapeutics.com
CHANGED 2017-01-27
CREATED 2008-10-25
STATUS clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Nous utilisons des cookies pour personnaliser votre expérience sur notre site. En poursuivant votre navigation, vous acceptez cette utilisation. Apprendre encore plus
domaintherapeutics.com rapport :
Visitez le site